Cargando…
The Path to Clinical Proteomics Research: Integration of Proteomics, Genomics, Clinical Laboratory and Regulatory Science
Better biomarkers are urgently needed to cancer detection, diagnosis, and prognosis. While the genomics community is making significant advances in understanding the molecular basis of disease, proteomics will delineate the functional units of a cell, proteins and their intricate interaction network...
Autores principales: | Boja, Emily S., Rodriguez, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116002/ https://www.ncbi.nlm.nih.gov/pubmed/21474978 http://dx.doi.org/10.3343/kjlm.2011.31.2.61 |
Ejemplares similares
-
Schizophrenia proteomics: biomarkers on the path to laboratory medicine?
por: Lakhan, Shaheen Emmanuel
Publicado: (2006) -
Integration of omics sciences to advance biology and medicine
por: Boja, Emily S, et al.
Publicado: (2014) -
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories
por: Birhanu, Alemayehu Godana
Publicado: (2023) -
Analytical Validation Considerations
of Multiplex
Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein
Biomarkers
por: Boja, Emily S., et al.
Publicado: (2014) -
Proteomic Research of Extracellular Vesicles in Clinical Biofluid
por: Fan, Shipan, et al.
Publicado: (2023)